psoriasis and semaglutide Emerging research suggests that GLP-1–based weight loss medications may offer dual benefits—supporting cardiovascular health while potentially improving by reducing systemic inflammation. Learn more : https://wb.md/4shrzWx GLP-1 Drugs Tackle Both Skin

10.1111/ene.14774 Eur

Treatment should be combined with nutrition, physical activity and regular clinical monitoring

82 HP 175 IGF-1 LR3 Long R3 IGF-1 extended half-life anabolic research compound ALIASES Long R3 IGF-1, LR3 IGF-1, IGF-1LR3, IGF1 LR3 CLASS Synthetic 83-residue insulin-like growth factor 1 analog FORMULA C400H625N111O115S9 HALF-LIFE ~6 hours (vs ~10 minutes native IGF-1) ROUTES Subcutaneous (research) MECHANISM OF ACTION Long R3 Insulin-like Growth Factor 1 83-residue synthetic analog of native IGF-1 with N-terminal 13-residue extension and Arg substitution at position 3

My cousin in Toronto told me about BPC-157 after his tennis elbow cleared up

Alsin/Rac1 signaling controls survival and growth of spinal motoneurons

These are well recognized as triggers for enteritis